Alon Mualem, Chief Financial Officer of Wearable Devices Ltd., filed a Form 4 on November 9, 2026, disclosing the acquisition of 60,000 Restricted Share Units on November 5, 2026, at no cost under the company's 2024 Global Equity Incentive Plan.
Aric Spitulnik, a newly appointed director of Versus Systems Inc., filed an initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing no securities beneficially owned as of the event date of November 1, 2024.
Wearable Devices Ltd. Chief Operating Officer Tamar Fleisher filed a Form 4 on November 9, 2026, disclosing the acquisition of 20,000 Restricted Share Units on November 5, 2026.
Livia Desenso Monteiro, HR and Corporate Affairs Officer at Nexa Resources S.A., filed a Form 3 initial statement of beneficial ownership with the SEC on November 9, 2026, reporting no securities beneficially owned.
CorMedix Inc. filed a Form 8-K on November 9, 2026, disclosing that on November 8, 2026 it entered into an Asset Purchase Agreement with Heron Therapeutics, Inc. to acquire substantially all of Heron's assets for a combination of cash, stock, royalties, and contingent earn-out …
CorMedix Inc. filed a current report on November 9, 2026, disclosing an Asset Purchase Agreement signed November 8, 2026, under which the company agreed to acquire substantially all assets of Heron Therapeutics, Inc. for a combination of cash, stock, royalties, and contingent earn-out payments.
Robbins LLP announced on November 9, 2026, that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Tigo Energy (NASDAQ:TYGO) securities between February 24, 2026 and August 4, 2026.
Director Paul W. Harvey filed a Form 4 with the SEC on November 9, 2026, disclosing a purchase of 500 shares of Matador Resources Co common stock on November 5, 2026, at a price of $52.72 per share.
SciSparc Ltd. filed a Form 6-K/A on November 9, 2026, amending its November 3, 2026 Form 6-K to correct a typographical error in the Floor Price contained in a Convertible Promissory Note and related Warrant issued to L.I.A. Pure Capital Ltd.
Davion Healthcare Plc filed a Form 6-K on November 9, 2026, disclosing that it entered into a non-exclusive financial advisory agreement with Vienna Capital Partners LLC to support a proposed acquisition financing strategy for 2027.